QUALITY ASSISTANCE S.A.
Nathalie Draux has a diverse work experience spanning over two decades. Nathalie currently holds the position of CEO at Quality Assistance S.A., a role they assumed in January 2023. Prior to this, they served as the Chief Operations Officer and Chief Innovation Officer at the same company from October 2016 to December 2022 and from January 2013 to December 2022, respectively. Nathalie has also held various positions in business development, corporate communication management, and account management at Quality Assistance S.A. from 2008 to 2012. Nathalie has a background in quality control and quality assurance, having started their career as a Quality Control Analyst / Validation Assistant in 2001 and eventually becoming a Quality Assurance Associate in 2004. Nathalie has also held positions in training operations and as a head pharmacist associate. Additionally, Nathalie has served as a member of the board for various organizations including Grand Hôpital de Charleroi, essenscia, and SOWALFIN.
Nathalie Draux completed their Master in Pharmacy at Université catholique de Louvain from 1996 to 2001, with a field of study in Sciences pharmaceutiques. Nathalie then pursued an Advanced Master in Industrial Pharmacy at the same university from 2001 to 2003. In 2015, Nathalie enrolled in the Management Acceleration Programme at Vlerick Business School, completing it in 2016.
This person is not in any teams
QUALITY ASSISTANCE S.A.
Quality Assistance S.A. is a leading European Contract Research Organisation (CRO) providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products. We assist our clients through non-clinical and clinical studies to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences. For each client project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs. Quality Assistance S.A. is an expert for the development of : - Biotherapeutics, monoclonal antibodies, ADCs - New Chemical Entities, peptides, oligonucleotides - mRNA - Viral vectors - Vaccines - Cell-Based Medicinal Products - Nanomedicines The company holds a unique position on the market with : - all its laboratories on one site : Bioanalysis, Bioassays, Biochemistry, Chromatography, Elemental Impurities, Mass Spectrometry, Microbiology, Molecular Biology, Protein Characterisation - 250 highly qualified professionals - over 40 years’ expertise at the forefront of analytical sciences. The Quality Assistance environment is GMP, GLP and GCLP/GCP compliant. Visit www.quality-assistance.com to learn more about our expertise and analytical services.